News from Cambridge Enterprise.
What excites Steve Jackson is understanding how biology works and why it sometimes goes wrong. But what galvanises him is knowing there are people alive today as a result of his discovery of how to create a cancer drug.
Cambridge spinout, Echion Technologies has raised £29 million in investment capital to help it increase the production of its fast-charging, long-life battery material based on niobium.
Cambridge scientists have grown ‘mini-guts’ in the lab to help understand Crohn’s disease, showing that ‘switches’ that modify DNA in gut cells play an important role in the disease and how it presents in patients.
Researchers have developed a low-cost, energy-efficient method for making materials that can capture carbon dioxide directly from the air.
Diarmuid O'Brien, the University's new Pro-Vice-Chancellor for Innovation on what makes Cambridge such an enterprising place and what we can achieve through partnerships and our innovation ecosystem.
Researchers have developed a method to make adaptive and eco-friendly sensors that can be directly and imperceptibly printed onto a wide range of biological surfaces, whether that’s a finger or a flower petal.
Meet the brilliant founder and CEO of Nu Quantum, a Cambridge spinout paving the way for a new era of quantum computing.
Meet Umaima Ahmad, co-founder and CEO of a Cambridge spinout that aims to keep chemotherapy patients safe from infection while sparing them unnecessary hospital visits.
Dr Diarmuid O’Brien has been appointed as the University of Cambridge’s new Pro-Vice-Chancellor for Innovation. He is currently Chief Executive of Cambridge Enterprise, the University’s commercialisation arm which supports academics, researchers, staff and students in achieving knowledge transfer and research impact.
© 2025 University of Cambridge
